Latest Security News

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.

Lloyds Banking Group is set to acquire London-based fintech Curve, aiming to enhance its mobile banking with advanced digital wallet features. The deal, expected to close in early 2026, marks a strategic push in Lloyds’ digital transformation journey.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition, ordering Cosette Pharmaceuticals to comply with conditions preventing closure of the Salisbury manufacturing site. This ruling highlights concerns over market transparency and the integrity of the takeover process.

Astron Limited has received a pivotal Australian Taxation Office Class Ruling confirming capital gains tax roll-over relief for shareholders following its redomicile from Hong Kong to Australia. This development streamlines the company’s structure and offers potential long-term benefits to investors.

Bentley Capital Limited has reached a confidential settlement with Keybridge Capital Limited, receiving $250,000 to resolve a protracted legal dispute over shared legal costs.

Tasmea Limited has announced the acquisition of WorkPac Group for up to A$60.7 million, significantly enhancing its workforce solutions capabilities and positioning the company for growth amid Australia's skilled labour shortages.

Tasmea Limited reported a stellar FY25 with strong revenue and profit growth, bolstered by strategic acquisitions and a robust dividend payout. The company signals continued momentum with a new acquisition announcement and targets ASX300 inclusion in 2026.

Tasmea Limited reported robust FY25 financial results with a 74% jump in net profit after tax, driven by organic growth and strategic acquisitions. The company reaffirmed its FY26 guidance, supported by a $43 million institutional placement to fuel further expansion.

Garda Property Group has completed the $113.6 million sale of its North Lakes industrial site, sharply reducing debt and focusing its portfolio exclusively on Brisbane industrial assets. The group also secured a three-year extension on its debt facility with improved pricing, positioning itself for selective growth in private lending.

Altamin Limited has appointed GBA Capital as lead manager to place shortfall shares from its recent entitlement offer, offering broker options as part of the arrangement. This move aims to bolster support for its critical minerals projects in Italy while engaging new and existing investors.

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.